PharmaCorp Rx Inc. (TSXV:PCRX)
Canada
· Delayed Price · Currency is CAD 0.4900
0.00 (0.00%)
May 1, 2025, 4:00 PM EDT
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 57.07 million as of May 2, 2025.
Market Cap
57.07M
Enterprise Value
45.36M
Revenue
5.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 57.07M, an increase of 2,277.97%. That is a compound annual growth rate of 239.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 57.07M | -9.87% |
| Dec 31, 2024 | 63.32M | 427.65% |
| Dec 30, 2022 | 12.00M | 400.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royal Bank of Canada | 234.35B |
| The Toronto-Dominion Bank | 153.37B |
| Enbridge | 140.60B |
| Brookfield Asset Management | 120.22B |
| Thomson Reuters | 114.74B |
| Brookfield | 111.21B |
| Constellation Software | 105.58B |
| Bank of Montreal | 95.93B |